| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $410.6M | -0.8% |
| Cost of Revenue | $3.1M | — |
| R&D Expense | $44.3M | -37.1% |
| SG&A Expense | $116.0M | +4.4% |
| Operating Income | $250.3M | +7.8% |
| Interest Expense | $7.6M | -75.6% |
| Pre-tax Income | $252.4M | +25.8% |
| Income Tax | $77.4M | +123.6% |
| Net Income | $175.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $656.2M | +5.8% |
| Accounts Receivable | $115.5M | +1.2% |
| Current Assets | $780.6M | +4.8% |
| Total Assets | $1.10B | -2.3% |
| Current Liabilities | $25.5M | -84.2% |
| Long-term Debt | $396.3M | -12.8% |
| Stockholders' Equity | $652.4M | +7.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $273.8M | +4.5% |
| Capital Expenditures | $136K | -48.7% |
| Investing Cash Flow | -$136K | +48.7% |
| Financing Cash Flow | -$237.6M | -5120.9% |
| Free Cash Flow | $273.6M | +4.6% |
| -66.9% |
| EPS (Basic) | $1.13 | -65.3% |
| EPS (Diluted) | $0.96 | -70.1% |